Decision making and decision support for hereditary breast-ovarian cancer susceptibility

Health Psychology

Volumn 24, Issue 4 SUPPL., 2005, Pages

  Schwartz, Marc D ^a,c   Peshkin, Beth N ^a,c   Tercyak, Kenneth P ^a,c   Taylor, Kathryn L ^a,c   Valdimarsdottir, Heiddis ^b  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c GEORGETOWN UNIVERSITY   (United States)

Author keywords

BRCA1; BRCA2; Decision making

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; RALOXIFENE; TAMOXIFEN;

AFFECT; ALGORITHM; ANXIETY; BREAST CANCER; CANCER SURGERY; CANCER SUSCEPTIBILITY; DECISION SUPPORT SYSTEM; FAMILIAL CANCER; GENE MUTATION; GENETIC ANALYSIS; GENETIC COUNSELING; HEALTH BEHAVIOR; HETEROZYGOTE; HUMAN; MEDICAL DECISION MAKING; OVARY CANCER; PREDICTION; REVIEW;

BREAST NEOPLASMS; DECISION MAKING; DNA MUTATIONAL ANALYSIS; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HUMANS; OVARIAN NEOPLASMS; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT PARTICIPATION; UNITED STATES;

EID: 23244465320     PISSN: 02786133     EISSN: None     Source Type: Journal    
DOI: 10.1037/0278-6133.24.4.S78     Document Type: Review

References (50)

1. Antoniou, A., Pharoah, P. D., Narod, S., Risch, H. A., Eyfjord, J. E., & Hopper, J. L. (2003). Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in cases unselected for family history: A combined analysis of 22 studies. American Journal of Human Genetics, 72, 1117-1130.
2. Armstrong, K., Calzone, K., Stopfer, J., Fitzgerald, G., Coyne, J., & Weber, B. (2000). Factors associated with decisions about clinical BRCA1/2 testing. Cancer Epidemiology, Biomarkers & Prevention, 9, 1251-1254.
3. Armstrong, K., Schwartz, J. S., Randall, T., Rubin, S. C., & Weber, B. (2004). Hormone replacement therapy and life expectancy after prophylactic oophorectomy in women with BRCA1/2 mutations: A decision analysis. Journal of Clinical Oncology, 22, 1045-1054.
4. Biesecker, B. B., Ishibe, N., Hadley, D. W., Giambarresi, T. R., Kase, R. G., Lerman, C., et al. (2000). Psychosocial factors predicting BRCA1/BRCA2 testing decisions in members of hereditary breast and ovarian cancer families. American Journal of Medical Genetics, 93, 257-263.
5. Botkin, J. R., Smith, K. R., Croyle, R. T., Baty, B. J., Wylie, J. E., Dutson, D., et al. (2003). Genetic testing for a BRCA1 mutation: Prophylactic surgery and screening behavior in women 2 years post testing. American Journal of Medical Genetics, 118A, 201-209.
6. Boyd, N. F., Sutherland, H. J., & Heasman, K. Z. (1990). Whose utilities for decision analysis? Medical Decision Making, 10, 58-67.
7. Braithwaite, D., Emery, J., Walter, F., Prevost, A. T., & Sutton, S. (2004). Psychological impact of genetic counseling for familial breast cancer: A systematic review and meta analysis. Journal of the National Cancer Institute, 96, 122-133.
8. Cull, A., Miller, H., Porterfield, T., Mackay, J., Anderson, E. D., Steel, C. M., et al. (1998). The use of videotaped information in cancer genetic counselling: A randomized evaluation study. British Journal of Cancer, 77, 830-837.
9. Dorval, M., Patenaude, A. F., Schneider, K. A., Kieffer, S. A., DiGianni, L., Kalkbrenner, K. J., et al. (2000). Anticipated versus actual emotional reactions to disclosure of results of genetic tests for cancer susceptibility: Findings from p53 and BRCA1 testing programs. Journal of Clinical Oncology, 18, 2135-2142.
10. Easton, D. F., Ford, D., & Bishop, D. T. (1995). Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. American Journal of Human Genetics, 56, 265-271.
11. Fry, A., Rush, R., Busby-Earle, C., & Cull, A. (2001). Deciding about prophylactic oophorectomy: What is important to women at increased risk of ovarian cancer? Preventive Medicine, 33, 578-585.
12. Gillis, J. S. (1993). Effects of life stress and dysphoria on complex judgments. Psychological Reports, 72, 1355-1363.
13. Green, M. J., Biesecker, B. B., McInerney, A. M., Mauger, D., & Fost, N. (2001). An interactive computer program can effectively educate patients about genetic testing for breast cancer susceptibility. American Journal of Medical Genetics, 103(1), 16-23.
14. Green, M. J., Peterson, S. K., Baker, M. W., Harper, G. R., Friedman, L. C., Rubinstein, W. S., et al. (2004). Effect of a computer-based decision aid on knowledge, perceptions, and intentions about genetic testing for breast cancer susceptibility: A randomized controlled trial. Journal of the American Medical Association, 292, 442-452.
15. Gurmankin, A. D., Baron, J., Hershey, J. C., & Ubel, P. A. (2002). The role of physicians' recommendations in medical treatment decisions. Medical Decision Making, 22, 262-271.
16. Guttmacher, A. E., & Collins, F. S. (2002). Genomic medicine: A primer. New England Journal of Medicine, 347, 1512-1520.
17. Hurley, K. E., Miller, S. M., Costalas, J. W., Gillespie, D., & Daly, M. B. (2001). Anxiety/uncertainty reduction as a motivation for interest in prophylactic oophorectomy in women with a family history of ovarian cancer. Journal of Women's Health & Gender-Based Medicine, 10, 189-199.
18. Johnson, E. J., Steffel, M., & Goldstein, D. G. (2005). Making better decisions: From measuring to constructing preferences. Health Psychology, 24(Suppl. 4), S17-S22.
19. Kaufman, E. M., Peshkin, B. N., Lawrence, W., Shelby, R., Isaacs, C., Brown, K., et al. (2003). Development of an interactive decision aid for female BRCA1/BRCA2 carriers. Journal of Genetic Counseling, 12(2), 109-129.
20. Khoury, M. J., McCabe, L. L., & McCabe, E. R. (2003). Population screening in the age of genomic medicine. New England Journal of Medicine, 348, 50-58.
21. King, M. C., Wieand, S., Hale, K., Lee, M., Walsh, T., Owens, K., et al. (2001). Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial. Journal of the American Medical Association, 286, 2251-2256.
22. Kuhl, C. K., Schrading, S., Leutner, C. C., Morakkabati, N., Trog, D., Schmutzler, R., et al. (2003). Surveillance of "high risk" women with proven or suspected familial (hereditary) breast cancer: First mid-term results of a multi-modality clinical screening trial. Proceedings of the American Society of Clinical Oncology, 22, A4.
23. Lee, S. C., Bernhardt, B. A., & Helzlsouer, K. J. (2002). Utilization of BRCA1/2 generic testing in the clinical setting: Report from a single institution. Cancer, 94, 1876-1885.
24. Lerman, C., Hughes, C., Croyle, R. T., Main, D., Durham, C., Snyder, C., et al. (2000). Prophylactic surgery decisions and surveillance practices one year following BRCA1/2 testing. Preventive Medicine, 31, 75-80.
25. Lerman, C., Lustbader, E., Rimer, B., Daly, M., Miller, S., Sands, C., et al. (1995). Effects of individualized breast cancer risk counseling: A randomized trial. Journal of the National Cancer Institute, 87, 286-292.
26. Lerman, C., Narod, S., Schulman, K., Hughes, C., Gomez-Caminero, A., Bonney, G., et al. (1996). BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes. Journal of the American Medical Association, 275, 1885-1892.
27. Loewenstein, G. (1996). Out of control: Visceral influences on behavior. Organizational Behavior and Human Decision Processes, 65, 272-292.
28. Meijers-Heijboer, H., Verhoog, L. C., Brekelmans, C. T. M., Seynave, C., Tilaners-Linthorst, M. M., Wagner, A., et al. (2000). Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation. Lancet, 355, 2015-2020.
29. Miller, S. M., Fang, C. Y., Manne, S. L., Engstrom, P. F., & Daly, M. B. (1999). Decision making about prophylactic oophorectomy among at-risk women: Psychological influences and implications. Gynecologic Oncology, 75, 406-412.
30. Peshkin, B. N., Schwartz, M. D., Isaacs, C., Hughes, C., Main, D., & Lerman, C. (2002). Utilization of breast cancer screening in a clinically based sample of women after BRCA1/2 testing. Cancer Epidemiology, Biomarkers & Prevention, 11, 1115-1118.
31. Rebbeck, T. R., Friebel, T., Lynch, H. T., Neuhausen, S. L., van't Veer, L., Garber, J. E., et al. (2004). Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: The PROSE Study Group. Journal of Clinical Oncology, 22, 1055-1062.
32. Rebbeck, T. R., Lynch, H. T., Neuhausen, S. L., Narod, S. A., van't Veer, L., Garber, J. E., et al. (2002). Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. New England Journal of Medicine, 346, 1616-1622.
33. Scheuer, L., Kauff, N., Robson, M., Kelly, B., Barakat, R., Satagopan, J., et al. (2002). Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers. Journal of Clinical Oncology, 20, 1260-1268.
34. Scheuner, M. T., Yoon, P. W., & Khoury, M. J. (2004). Contribution of Mendelian disorders to common chronic disease: Opportunities for recognition, intervention, and prevention. American Journal of Medical Genetics, 125C, 50-65.
35. Schwartz, M.D., Kaufman, E., Peshkin, B., Isaacs, C., Hughes, C., Finch, C., et al. (2003) Ovarian cancer screening and prophylactic surgery in a clinic-based sample of women following BRCA1/2 testing. Journal of Clinical Oncology, 21, 4034-4041.
36. Schwartz, M. D., Lerman, C., Brogan, B., Peshkin, B. N., Halbert, C. H., DeMarco, T., et al. (2004). Impact of BRCA1/BRCA2 counseling and testing on newly diagnosed breast cancer patients. Journal of Clinical Oncology, 22, 1823-1829.
37. Schwartz, M. D., Peshkin, B., Lerman, C., Isaacs, C., Brogan, B., Lawrence, W., et al. (2005). Utilization of pre-surgery BRCA1/2 testing among newly diagnosed breast cancer patients. Cancer Epidemiology, Biomarkers and Prevention, 14, 1003-1007.
38. Shechter, M., & Zeidner, M. (1990). Anxiety: Towards a decision-theoretic perspective. British Journal of Mathematical and Statistical Psychology, 43, 15-28.
39. Sieff, E. M., Dawes, R. M., & Loewenstein, G. (1999). Anticipated versus actual reaction to HIV test results. American Journal of Psychology, 112, 297-311.
40. Slovic, P., Finucane, M. L., Peters, E., & MacGregor, D. G. (2004). Risk as analysis and risk as feelings: Some thoughts about affect, reason, risk and rationality. Risk Analysis, 24, 311-322.
41. Stefanek, M., Enger, C., Benkendorf, J., Flamm Honig, S., & Lerman, C. (1999). Bilateral prophylactic mastectomy: A vignette study. Preventive Medicine, 29, 216-221.
42. Tercyak, K. P., Lerman, C., Peshkin, B. N., Hughes, C., Main, D., Isaacs, C., et al. (2001). Effect of coping style and test result on anxiety among women participating in genetic counseling and testing for breast/ovarian cancer risk. Health Psychology, 20, 217-222.
43. Ubel, P. A., & Loewenstein, G. (1997). The role of decision analysis in informed consent: Choosing between intuition and systematicity. Social Science and Medicine, 44, 647-656.
44. Unic, I., Verhoef, L. C., Stalmeier, P.P., & van Daal, W. A. (2000). Prophylactic mastectomy or screening in women suspected to have the BRCA1/2 mutation: A prospective pilot study of women's treatment choices and medical and decision-analytic recommendations. Medical Decision Making, 20, 251-262.
45. Van Boven, L., Dunning, D., & Loewenstein, G. (2000). Egocentric empathy gaps between owners and buyers: Misperceptions of the endowment effect. Journal of Personality and Social Psychology, 79, 66-76.
46. van Dijk, S., Otten, W., Zoeteweij, M. W., Timmermans, D. R., van Asperen, C. J., Breuning, M. H., et al. (2003). Genetic counseling and the intention to undergo prophylactic mastectomy: Effects of breast cancer risk assessment. British Journal of Cancer, 88, 1675-1681.
47. van Roosmalen, M. S., Stalmeier, P. F., Verhoef, L. C., Hoekstra-Weebers, J. E., Oosterwijk, J. C., Hoogerbrugge, N., et al. (2004a). Randomised trial of a decision aid and its timing for women being tested for a BRCA1/2 mutation. British Journal of Cancer, 90, 333-342.
48. van Roosmalen, M. S., Stalmeier, P. F., Verhoef, L. C., Hoekstra-Weebers, J. E., Oosterwijk, J. C., Hoogerbrugge, N., et al. (2004b). Randomised trial of a shared decision-making intervention consisting of trade-offs and individualized treatment information for BRCA1/2 mutation carriers. Journal of Clinical Oncology, 22, 3293-3301.
49. van Roosmalen, M. S., Verhoef, L. C., Stalmeier, P. F., Hoogerbrugge, N., & van Daal, W. A. (2002). Decision analysis of prophylactic surgery or screening for BRCA1 mutation carriers: A more prominent role for oophorectomy. Journal of Clinical Oncology, 20, 2092-2100.
50. Weil, J. (2003). Psychosocial genetic counseling in the post-nondirective era: A point of view. Journal of Genetic Counseling, 12, 199-211.